Fabio Petrocca

FAQ About Fabio Petrocca

• What is Fabio Petrocca's address?

  Fabio Petrocca is located at
  Greater Boston, Greater Boston, United States

• What is Fabio Petrocca's job title?

  Fabio Petrocca is a
  I am an oncology physician-scientist who enjoys taking care of patients with cancer, studying the genetic and biological basis of their disease, and helping develop new technologies to advance cancer treatment. Between academia and industry, I have 20 years of experience in Oncology Research & Development across multiple therapeutic modalities (RNAi therapeutics, small molecules, adoptive cell therapy). Much of my work has been at the intersection of cancer biology and clinical development, spanning basic research, IND-enabling studies, and phase 1/2 clinical trials, including early development of idecabtagene vicleucel (aka ABECMA, bb2121, ide-cel), the first approved CAR T therapy for multiple myeloma. I am currently at Boston Medical Center, the largest safety net hospital in New England, to help bring CAR Ts and other innovative cancer therapies to all patients regardless of their socioeconomic circumstances, while also helping build new and transformative biotech companies to further advance the field and improve on currently available therapies. Bristol Myers Squibb

• What industry does Fabio Petrocca currently work in?

  Fabio Petrocca currently works in the
  Bristol Myers Squibb

• What is Fabio Petrocca's area of expertise?

  Fabio Petrocca specializes in
  I am an oncology physician-scientist who enjoys taking care of patients with cancer, studying the genetic and biological basis of their disease, and helping develop new technologies to advance cancer treatment. Between academia and industry, I have 20 years of experience in Oncology Research & Development across multiple therapeutic modalities (RNAi therapeutics, small molecules, adoptive cell therapy). Much of my work has been at the intersection of cancer biology and clinical development, spanning basic research, IND-enabling studies, and phase 1/2 clinical trials, including early development of idecabtagene vicleucel (aka ABECMA, bb2121, ide-cel), the first approved CAR T therapy for multiple myeloma. I am currently at Boston Medical Center, the largest safety net hospital in New England, to help bring CAR Ts and other innovative cancer therapies to all patients regardless of their socioeconomic circumstances, while also helping build new and transformative biotech companies to further advance the field and improve on currently available therapies.

• Which languages does Fabio Petrocca speak? 

  Fabio Petrocca speaks the following languages:
  No languages available.

• Which industries has Fabio Petrocca previously worked in?   

  Fabio Petrocca has prior experience in the following industries:
  Catamaran Bio , Bluebird Bio , Bluebird Bio , Boston University School Of Medicine , Karyopharm Therapeutics , Harvard Medical School , Boston Childrens Hospital , Harvard Medical School

• What is Fabio Petrocca’s work experience?  

  Fabio Petrocca has the following professional experience:
  Bristol Myers Squibb , Boston Medical Center , Tessera Therapeutics , Catamaran Bio , Boston Medical Center , Boston University School Of Medicine , Boston Medical Center , Bluebird Bio , Bluebird Bio , Boston University School Of Medicine , Karyopharm Therapeutics , Harvard Medical School , Boston Childrens Hospital , Harvard Medical School .

• How can I find Fabio Petrocca on LinkedIn?  

  You can view Fabio Petrocca’s
  LinkedIn profile at LinkedIn URL.

• What are Fabio Petrocca’s work email addresses?  

  Fabio Petrocca’s work email addresses are
  [email protected] .

• What company does Fabio Petrocca work for?  

  Fabio Petrocca works at
  Bristol Myers Squibb